Ingredient intelligence
Ascorbyl glucoside
Antioxidant · Ascorbyl Glucoside · C12H20O11
Ascorbyl glucoside is a glycosylated vitamin C derivative. It is more stable than L-ascorbic acid but must be cleaved by glucosidase activity to release ascorbate, and how efficiently that happens in human skin is not well quantified.
Molecular identity
- Formula
- C12H20O11
- Molecular weight
- 340.28 g/mol
- PubChem CID
- 54693473
- ChEBI
- Data unavailable
Biological targets
Alpha-glucosidase activity (cutaneous)
medium confidencetargets · enzyme
Required for conversion; the specific cutaneous isoform responsible is not firmly established — data unavailable.
Prolyl 4-hydroxylase subunit alpha-1 (P4HA1)
low confidenceactivates · enzyme
Ascorbate-dependent cofactor role, inferred from L-ascorbic acid biology.
UniProt P13674Tyrosinase (TYR)
low confidenceinhibits · enzyme
UniProt P14679
How could this ingredient interact with biology?
Biological network
Ingredient → molecule → target → gene/protein → pathway → process → studied outcome. Relationship strength is drawn from the curated confidence tier; nothing is added to make the chain look complete.
drag to pan · hover to isolate a path · click a node for detail
11 lower-confidence relationships are hidden at this filter level. Use “Show more biology” to include them.
Text alternative for this network
- Ascorbyl glucoside is molecule Ascorbyl glucoside — high confidence
- Ascorbyl glucoside is molecule L-ascorbic acid — high confidence
- Ascorbyl glucoside targets Alpha-glucosidase activity (cutaneous) — medium confidence
Biological pathways
Collagen biosynthesis and modifying enzymes
low confidenceAscorbate released from the glucoside can serve as cofactor for collagen prolyl hydroxylases.
Reactome R-HSA-1650814
Melanin biosynthesis
low confidencePigment endpoints reported for vitamin C derivatives, with limited derivative-specific data.
Gene Ontology GO:0042438
Evidence engine
Insufficient
Not enough curated evidence to characterise this ingredient.
Skinceptor Evidence Index
22
experimental · of 100
This index is a research-navigation aid describing how much evidence exists and how it was produced. It is not a medical safety score, an efficacy guarantee, or a clinical recommendation.
Study composition
- In-vitro1
- Review1
- Total studies
- 2
- Human studies
- 0
- Largest sample
- Data unavailable
- Range
- 2007–2020
Index breakdown
- Study design quality35% × 28%
Mean design weight across curated studies (meta-analysis 1.0, RCT 0.9, other human 0.7, review 0.45, animal 0.35, in-vitro 0.25).
- Human evidence share0% × 22%
Proportion of curated evidence measured in people rather than cells or animals.
- Evidence volume50% × 14%
Log-scaled count of curated studies, so volume alone cannot dominate the score.
- Largest sample size0% × 12%
Log-scaled largest reported sample size across curated human studies.
- Replication0% × 12%
Independent human studies, capped at three; one study is never treated as replicated.
- Recency70% × 7%
Linear decay over a twenty-year window from the most recent curated publication.
- Source traceability0% × 5%
Share of curated studies with a verified PMID or DOI in this dataset.
Insufficient comparable evidence for quantitative synthesis.
Research timeline
How the evidence accumulated
2007
Ascorbyl glucoside stability and enzymatic release of ascorbic acid in skin models
In-vitrosample size unavailable · International Journal of Cosmetic Science
2020
Vitamin C derivatives for facial hyperpigmentation: a narrative review
Reviewsample size unavailable · Journal of Cosmetic Dermatology (review)
Ingredient fingerprint
15 nodes · 22 relationships · seed "ascorbyl-glucoside"
The fingerprint is a deterministic visual signature: ridge amplitude comes from the number of entities in each tier, node placement from identifier hashes, and opacity from confidence. Two ingredients can never produce the same figure unless their networks are identical.
Open in Biology as Art →Research
2 curated studies
Vitamin C derivatives for facial hyperpigmentation: a narrative review
Concludes that derivative-specific human evidence is thinner than for L-ascorbic acid, with conversion efficiency the main open question.
Limitations — Review of heterogeneous small studies; identifier not verified during curation.
Ascorbyl glucoside stability and enzymatic release of ascorbic acid in skin models
Reported greater aqueous stability than L-ascorbic acid and glucosidase-dependent release of free ascorbate in skin homogenates.
Limitations — Homogenate model may overstate in-vivo conversion; identifier not verified during curation.
Community evidence
Submitted by readers
Reader submissions appear here only after review. They are not part of the curated dataset and do not affect the Skinceptor Evidence Index.
No approved community submissions yet.
Sources
- PubChem 54693473Verified 2026-09-14
- UniProt P13674Verified 2026-09-14
- Reactome R-HSA-1650814Verified 2026-09-14